University of Illinois at Chicago
Announcement of an Exempt Purchase
Vendor: Mallinckrodt-Therakos Incorporated, St. Louis, MO
Amount: An estimated $4,000,000
An estimated start date of 7/1/2020 through 6/30/2025
The University award process may be delayed up to thirty days as this award goes through a state approval process.
First published Tuesday, April 21, 2020
The University awarded a contract for INOmax therapeutic respiratory delivery systems.
INOmax (nitric oxide) therapeutic respiratory delivery systems required for the treatment of newborns with hypoxic respiratory failure.
This purchase is exempt from the usual selection processes of the Procurement Code because the procurement expenditure is for medical supplies or medical services necessary for the delivery of care and treatment at medical, dental, or veterinary teaching facilities utilized by SIU or U of I (30 ILCS 500 / 1-13(b-5)) The nitric oxide is needed for the therapeutic respiratory delivery systems. The FDA approved systems are used to treat newborns with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension. The therapeutic delivery systems consist of the following: mechanical ventilator, cylinder, calibration gases, injector modules, flowmeter kit, and tubing for the delivery of nitric oxide in purified form.
For instructions on how to obtain a comprehensive purchase description, disclosure or contract forms, contact:
The State of Illinois has a policy to encourage prospective vendors to hire
qualified veterans, minorities, females, persons with disabilities and ex-offenders.